Canadian companies send psilocybin package to Health Canada for pre-clinical trial application

The initial trial would focus on dosage before expanding into psilocybin treatments for a variety of health conditions.

The information package included the investigational product’s chemical constituents, genotype, and formulation as well as procedures and processes to produce a consistent dosage from psilocybe mushrooms. “Numinus is pleased to partner with Optimi on this important work and provide the expertise, licensed facility and specialized equipment required to quickly develop, formulate and rigorously test products derived from natural psilocybe sources and prepare them for Health Canada submissions and approvals,” said Sharan Sidhu, science officer and general manager of Numinus Bioscience.

المملكة العربية السعودية أحدث الأخبار, المملكة العربية السعودية عناوين

Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.

Canadian company wins COVID-19 vaccine deal with Bolivia – and WTO supportDeal between Bolivia and Biolyse Pharma could clear a viable new path to getting COVID-19 vaccines to lower-income countries, but it requires Ottawa’s support
مصدر: globeandmail - 🏆 5. / 92 اقرأ أكثر »